FDA Determines Regulatory Review Period for PHAKIC INTRAOCULAR LENSES Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for PHAKIC INTRAOCULAR LENSES, a type of medical device, in response to a patent extension application submitted to the US Patent and Trademark Office (USPTO).